FDA Sends Warning Letters to More Than 50 GLP 1 Compounders and Manufacturers Wilson Sonsini Compounded "semaglutide" is not FDA approved semaglutide.com In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few FDA Compliance for Peptide Therapy and BPC 157 Holt Law FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida